Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction

Circulation: Cardiovascular Imaging

Volumn 6, Issue 5, 2013, Pages 755-761

  Izquierdo, Maite ^a   Ruiz Granell, Ricardo ^a   Bonanad, Clara ^a   Chaustre, Fabian ^a   Gomez, Cristina ^a   Ferrero, Angel ^a   Lopez Lereu, Pilar ^b   Monmeneu, Jose V ^b   Nuñez, Julio ^a   Chorro, F Javier ^a   Bodi, Vicent ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b ERESA Hospital Clínic Universitari de València   (Spain)

Author keywords

Cardiac arrhythmias; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ARREST; HEART CATHETERIZATION; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH; SURVIVAL RATE;

CARDIAC ARRHYTHMIAS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION;

AGED; AREA UNDER CURVE; ARRHYTHMIAS, CARDIAC; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84884494611     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.000702     Document Type: Article

References (20)

1. Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005; 352: 2581-2588. (Pubitemid 41007844)
2. Zipes K, Camm J, Borggrefe M, Buxton A, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss A, Myerburg R, Priori S, Quinones M, Roden D, Silka M, Tracy C. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace. 2006; 8: 746-837.
3. Buxton A, Lee K, Fisher J, Josephson M, Prystowsky E, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999; 341: 1882-1890.
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346: 877-883. (Pubitemid 34984635)
5. Steinbeck G, Andresen D, Seidl K, Brachmann J, Hoffmann E, Wojciechowski D, Kornacewicz-Jach Z, Sredniawa B, Lupkovics G, Hofgärtner F, Lubinski A, Rosenqvist M, Habets A, Wegscheider K, Senges J; IRIS Investigators. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009; 361: 1427-1436.
6. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004; 351: 2481-2488. (Pubitemid 39603155)
7. Roes S, Borleffs JW, Geest R, Westenberg J, Marsan NA, Kaandorp T, Reiber J, Zeppenfeld K, Lamb H, Roos A, Schalij M, Bax J. Infarct tissue heterogeneity assessed with contrst-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverte- defibrillator. Circ Cardiovasc Imaging. 2009; 2: 183-190.
8. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, Gerstenblith G, Weiss RG, Marbán E, Tomaselli GF, Lima JA, Wu KC. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007; 115: 2006-2014. (Pubitemid 46625951)
9. Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM, Taylor AJ. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2011; 57: 821-828.
10. Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B, Parker MA, Judd RM, Kim RJ. Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol. 2012; 60: 408-420.
11. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005; 45: 1104-1108. (Pubitemid 40432446)
12. Bodi V, Husser, O, Sanchis J, Nunez J, Lopez-Lereu M, Monmeneu JV, Mainar L, Chaustre F, RIegger G, Bosch M, Chorro FJ, Llacer A. Contractile reserve and extent of transmural necrosis in the setting of myocardial stunning. Radiology. 2010; 255: 755-763.
13. Bodí V, Sanchis J, López-Lereu MP, Losada A, Núñez J, Pellicer M, Bertomeu V, Chorro FJ, Llácer A. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol. 2005; 46: 1747-1752. (Pubitemid 41531634)
14. Monmeneu JV, Bodí V, López-Lereu MP, Sanchis J, Núñez J, Chaustre F, Husser O, Merlos P, Bonanad C, Miñana G, Chorro FJ, Llácer A. Analysis of post-infarction salvaged myocardium by cardiac magnetic resonance. Predictors and influence on adverse ventricular remodeling. Rev Esp Cardiol (Engl Ed). 2012; 65: 634-641.
15. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Juhani Airaksinen KE, Myerburg RJ. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol. 2003; 42: 652-658. (Pubitemid 37000180)
16. Maggioni A, Zuanetti G, Franzosi M, rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. Circulation. 1993; 87: 312-322. (Pubitemid 23040899)
17. Buxton AE. Sudden death after myocardial infarction-who needs prophylaxis, and when? N Engl J Med. 2005; 352: 2638-2640. (Pubitemid 41007851)
18. Godberger J, Cain M, Hohnloser S, Kadish A, Knight B, Lauer M, Maron B, Page R, Passman R, Siseovick D, Stevenson W, Zipes D. American Heart Association/American College of Cardiology Foundation/ Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocrdiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation. 2008; 118: 1497-1518.
19. Jones-Collins BA, Patterson RE. Quantitative measurement of electrical instability as a function of myocardial infarct size in the dog. Am J Cardiol. 1981; 48: 858-863. (Pubitemid 12003535)
20. Arenal A, Hernández J, Pérez-David E, Rubio-Guivernau JL, Ledesma-Carbayo MJ, Fernández-Avilés F. Do the spatial characteristics of myocar-dial scar tissue determine the risk of ventricular arrhythmias? Cardiovasc Res. 2012; 94: 324-332.